Other mutations involving either exon 17 or other exons of KIT (e.g. exons 8, 9, 10 and 11), or a wild-type KIT receptor can be detected in a small percentage of SM patients (∼3% and ∼6%, respectively) [6, 9–18]. Here, KIT is linked to systemic mastocytosis.